AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 292: R697-R699, 2007. First published November 9, 2006; doi:10.1152/ajpregu.00766.2006
0363-6119/07 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/R697    most recent
00766.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denton, K.
Right arrow Articles by Baylis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denton, K.
Right arrow Articles by Baylis, C.

IN FOCUS

CALL FOR PAPERS
Sex Differences in Renal and Cardiovascular Function: Physiology and Pathophysiology

Physiological and molecular mechanisms governing sexual dimorphism of kidney, cardiac, and vascular function

Kate Denton1 and Chris Baylis2

1Department of Physiology, Monash University, Melbourne, Australia and 2Departments of Physiology and Medicine, University of Florida, Gainesville, Florida

IT IS WELL ESTABLISHED THAT cardiovascular disease is a leading cause of death in developed countries, but it is less well known that more women than men die of cardiovascular disease, although these deaths are delayed by ~10 yr (7, 17). It is becoming evident that there is considerable sexual dimorphism in the pathogenesis of cardiovascular disease. Thus findings from past studies, mostly in males, do not automatically apply to females. Reflecting a recognition of this sexual dimorphism, this call for papers on Sex Differences in Renal and Cardiovascular Function: Physiology and Pathophysiology produced an excellent response, with 21 original manuscripts appearing in this issue of the American Journal of Physiology–Regulatory, Integrative and Comparative Physiology, as well as several more to appear in later issues. These works encompass the field of physiological and molecular mechanisms governing sexual dimorphism of kidney, cardiac, and vascular function and include basic and translational studies.

Coronary artery disease is the number 1 cause of death in industrialized countries, and recent evidence shows that women experience higher mortality and poorer outcomes after myocardial infarction than men (10, 17). It is only in the last decade that specific guidelines for cardiovascular disease prevention in women have been formulated (19). One fundamental question is whether there are intrinsic sex differences in myocardial function. Battiprolu et al. (2) in this issue showed that even before sexual maturity, cardiac tissue from female rainbow trout tends to use glycolysis for ATP production, whereas males have a higher capacity for aerobic and lipid metabolism. Petre et al. (24) concluded that the basic mechanical performance of healthy isolated feline myocardium was not different between males and females under physiological conditions; however, under conditions of physiological stress, sex differences in myocardial function emerge that may reflect sex differences in intracellular calcium regulation in cardiac myocytes. Chronic alcohol consumption leads to cardiomyopathy, and Vary et al. (31) demonstrated sexual dimorphism in the cardiac response to heavy alcohol consumption with inhibition of protein synthesis in male (but not female) rats. This was associated with limitation of mRNA translation due to a reduction in activation (phosphorylation) of a specific eukaryotic initiation factor (eIF4G). Hunter et al. (8) investigated the susceptibility of the aging female rat heart to ischemia-reperfusion-induced injury and concluded that aging alone, independent of plasma estrogen levels, leads to reduced ischemic tolerance, although this is exacerbated by estrogen deficiency. Bupha-Intr et al. (3a) indicate that estrogen deficiency enhances calcium sensitivity of myofilaments in cardiac myocytes by a pH-dependent effect mediated by the sodium/hydrogen exchanger. Thawornkaiwong et al. (30) address the loss of cardioprotective actions of estrogen seen in diabetes and conclude that in rat heart, both estrogen and insulin are required for optimal cardioprotection, with estrogen acting to reduce cardiac beta-receptor expression.

In nondiabetic chronic kidney disease (CKD), the female shows a slower rate of progression than the male (20), but this is lost in diabetic nephropathy, and Mankhey et al. (16) suggest that this is due to inadequate estrogen since supplementation attenuates glomerular and tubulointerstitial fibrosis by both reducing extracellular matrix synthesis and stimulating degradation. Rogers et al. (26) have shown that estrogen regulates (reduces) the angiotensin AT1-receptor level in renal cortex, as well as upregulating the estrogen receptor-{alpha}, both likely to be renal protective actions during CKD. Sullivan et al. (28) examined reactive oxygen species production in the renal inner medulla in the spontaneously hypertensive rat (SHR) as a potential explanation of the blunted pressure-natriuresis relationship observed in male compared with female SHR. However, whereas urinary excretion of hydrogen peroxide was increased in male SHR compared with female rats, medullary hydrogen peroxide production was not. In fact, evidence suggested medullary antioxidant capability was increased. Possibly this represents a compensatory response by the renal medulla to offset increased superoxide production elsewhere. Yameleyeva et al. (32) report that in the female mRen2 rat, ovariectomy greatly exacerbates the hypertension with an associated decline in renal endothelial nitric oxide synthase (NOS) and increased renal neuronal NOS (nNOS) abundance. Interestingly, this increased nNOS may be pathogenic since "selective" nNOS inhibition with N5-(1-imino-3-butenyl)-L-ornithine prevented the ovariectomy-induced rise in arterial pressure. Perucca et al. (23) conducted a retrospective analysis of a number of clinical studies and make the novel observation that urine osmolarity is greater in men than women in health and during development of CKD. This will likely explain the greater susceptibility of men to development of urolithiasis, and, if related to greater activity of antidiuretic hormone, could also contribute to the increased rate of progression of CKD.

Sex-specific differences in vascular function have been extensively studied, with vascular contraction being greater in intact males compared with intact females. These differences have in large part been attributed to the impact of the sex hormones (estrogen, progesterone, and testosterone), which have been shown to influence vascular function significantly (11). Work now concentrates on understanding the cellular and molecular pathways involved. Paul et al. (22) report that the sex difference in aortic contractility may be related to actions of estrogen on both vascular endothelial and smooth muscle cells. They report an estrogen-induced shift in the COOH-terminal myosin heavy chain isoforms SM1-to-SM2 ratio, and while estrogen reduces the contractile response to KCl-depolarization, it evokes an unexpected increase in sensitivity to norepinephrine-induced contraction. Loss of female hormones have been strongly linked to vascular injury and the development of atherosclerosis (18) although this is controversial given clinical data suggesting negative cardiovascular actions with estrogen replacement (5). Benton et al. (3) investigated the interaction of diabetes and loss of ovarian hormones on atheroma formation in a mouse model of type 1 diabetes. Ultrastructural studies suggested that estrogen deficiency increases vascular permeability by promoting endothelial disruption, thus contributing to atheroma formation (3). These studies suggest that estrogen may play an important role in maintaining cell adhesion molecules. Following vascular injury, the estrogen receptor-beta (ER-beta), is upregulated (3). Rayner et al. (25) are searching for regulatory proteins that associate with ER-beta to determine its biological action. Here they report the finding of a novel protein, NM23-H2, that interacts with ER-beta and suggest it plays an important role in the regulation of estrogenic effects in the vascular wall. Furthermore, the results contain hints that there may be sex differences in the protein’s expression that warrant further investigation. Whereas much emphasis is placed on the protective actions of female hormones on the cardiovascular system, there is also some evidence that the androgens can be damaging. Iliescu et al. (9) report that androgens exacerbate hypertension in the SHR via an NADPH-oxidase-dependent mechanism involving increased p47phox and gp91phox subunits (9). There are some conditions in which female sex is a cardiovascular risk factor, notably the development of cardiovascular disease in systemic lupus erythematosus (SLE). Using a mouse model of SLE, Ryan and McLemore (27) reported development of an early endothelial dysfunction in females preceding the development of hypertension. This promises to be a useful model for investigation of the causes of cardiovascular injury during SLE, as well as interactions with sex hormones.

Much less emphasis has been directed at understanding the regulation of the venous side of the circulatory system. Venous reserve plays an important role in maintaining venous return and therefore arterial pressure. Orthostatic tolerance is maintained by alteration in venous compliance of the lower limbs. Women are much less tolerant of orthostatic stress, and the study of Lindenberger and Lanne (14) demonstrates that while the venous compliance response to lower-body negative pressure was not different in men and women, when differences in calf capillary fluid filtration were subtracted from the equation, significance differences were noted. The impact of estrogen on the venous microcirculation was discussed as a possible explanation of the differences in capillary fluid filtration.

There is now compelling evidence that events occurring during fetal life can have life-long consequences for the health of the adult. This concept was first described by Barker et al. (1) who observed an inverse relationship between birth weight and cardiovascular disease in a cohort of middle-aged men. Of concern is the accumulating evidence now suggesting that altered fetal development can occur independently of low birth weight (4), suggesting that the health implications are much greater than predicted by the proportion of babies suffering growth restriction. In this issue, the study of Maduwegedera et al. (15) suggests that the renal sympathetic innervation density was increased in offspring prior to the development of hypertension in the absence of decreased birth weight. This is of particular interest given the strong evidence in humans that the renal sympathetic nerves play a role in the initiation and maintenance of essential hypertension (6). Furthermore, the study of Ojeda et al. (21) highlights evidence that there are sex-specific differences in the fetal programming of hypertension in that in many models, male and female offspring are not equally affected. In their model, young male and female offspring have increased blood pressure, but only males remain hypertensive as adults. This persistent hypertension in the males was apparently related to androgen-induced activation of the renin-angiotensin system (21). An interesting corollary to this study would be to determine whether the increased blood pressure in young female rat pups that does not progress into adulthood might become overt in aged females as estrogen levels decline.

The nervous system exerts important control over cardiovascular functions, and the clinical studies of Lavi et al. (13) suggest that aging, rather than decreased estrogen levels, contribute to increased cardiovascular risk in postmenopausal women, due in part to a shift from parasympathetic to predominantly sympathetic control of the circulation. These changes are similar to those seen in aging men, suggesting independence from sex hormones. Men generally exhibit greater autonomic responses to stress compared with women, and Kimmerly et al. (12) have investigated central nervous system control of baroreceptor unloading (using the physiological challenge of lower negative body pressure), which is greater in men than in women. Forebrain activity was assessed using functional magnetic resonance imaging with blood oxygen level-dependent contrast (BOLD) in conjunction with muscle sympathetic nerve activity (MSNA) recordings to investigate this sex-dependent difference in autonomic control. Their findings demonstrated differential regional alterations in BOLD signals in the forebrain in response to lower-body negative pressure in association with changes in heart rate and MSNA and the responses were greater in men than women (12). Although these results do not represent direct evidence that differences in forebrain activation are responsible, the enhanced sympathetic outflow in men, in response to lower-body negative pressure and baroreceptor unloading, certainly add weight to the postulate that central processing is controlled differently in men and women.

The Future

We live in an aging society, with life expectancy far greater today than a century ago. The challenge for modern medicine is how to increase the number of disease-free years as people age and improve quality of life in later years. The process of aging is associated with the deterioration of the body, including the cardiovascular system. It has become apparent that to improve diagnosis and treatment for both men and women the differences in circulatory control must be addressed. Despite the cost in terms of housing and time, longer-term studies in older cohorts of animals are required to examine the impact of age and sex on cardiovascular health. The impact of the menstrual cycle on physiological function and drug therapy should also be taken into consideration.

FOOTNOTES


Address for reprint requests and other correspondence: K. Denton, Dept. of Physiology, Bldg. 13F, Monash Univ., Clayton, Victoria, Australia, 3800 (E-mail: kate.denton{at}med.monash.edu.au)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

REFERENCES

  1. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 298: 564–567, 1989.[ISI][Medline]
  2. Battiprolu PK, Harmon KJ, Rodnick KJ. Sex differences in energy metabolism and performance of teleost cardiac tissue. Am J Physiol Regul Integr Comp Physiol 292: R827–R836, 2007.[Abstract/Free Full Text]
  3. Benton J, Powers A, Eiselein L, Fitch R, Wilson D, Villablanca AC, Rutledge JC. Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability. Am J Physiol Regul Integr Comp Physiol 292: R723–R730, 2007.[Abstract/Free Full Text]
  4. Bupha-Intr T, Wattanapermpool J, Peña JR, Wolska BM, Solaro RJ. Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis. Am J Physiol Regul Integr Comp Physiol 292: R837–R843, 2007.[Abstract/Free Full Text]
  5. Denton KM, Kett MM, Dodic M. Programming hypertension–animal models: causes and mechanisms. In: Early Life Origins of Health and Disease, edited by Wintour EM and Owens JA. New York: Landes Bioscience, 2006, p. 103–129.
  6. Dubey RK, Imthurn B, Zacharia LC, Jackson EK. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here? Hypertension 44: 789–795, 2004.[Abstract/Free Full Text]
  7. Esler M. Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol 26: S24–S28, 1995.
  8. Giardina EG. Heart disease in women. Int J Fertil Womens Med 45: 350–357, 2000.[ISI][Medline]
  9. Hunter JC, Kostyak JC, Novotny JL, Simpson AM, Korzick DH. Estrogen deficiency decreases ischemic tolerance in aged rat heart: roles of PKC{delta}, PKC{epsilon}, Akt, and GSK3beta. Am J Physiol Regul Integr Comp Physiol 292: R800–R809, 2007.[Abstract/Free Full Text]
  10. Iliescu R, Cucchiarelli VE, Yanes LL, Iles JW, Reckelhoff JF. Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol 292: R731–R735, 2007.[Abstract/Free Full Text]
  11. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation 108: 1089–1094, 2003.
  12. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46: 249–254, 2005.[Abstract/Free Full Text]
  13. Kimmerly DS, Wong S, Menon R, Shoemaker JK. Forebrain neural patterns associated with sex differences in autonomic and cardiovascular function during baroreceptor unloading. Am J Physiol Regul Integr Comp Physiol 292: R715–R722, 2007.[Abstract/Free Full Text]
  14. Lavi S, Nevo O, Thaler I, Rosenfeld R, Dayan L, Hirshoren N, Gepstein L, Jacob G. Effect of aging on the cardiovascular regulatory systems in healthy women. Am J Physiol Regul Integr Comp Physiol 292: R788–R793, 2007.[Abstract/Free Full Text]
  15. Lindenberger M, Länne T. Sex-related effects on venous compliance and capillary filtration in the lower limb. Am J Physiol Regul Integr Comp Physiol 292: R852–R859, 2007.[Abstract/Free Full Text]
  16. Maduwegedera D, Kett MM, Flower RL, Lambert GW, Bertram JF, Wintour ME, Denton KM. Sex differences in postnatal growth and renal development in offspring of rabbit mothers with chronic secondary hypertension. Am J Physiol Regul Integr Comp Physiol 292: R706–R714, 2007.[Abstract/Free Full Text]
  17. Mankhey RW, Wells CC, Bhatti F, Maric C. 17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 292: R769–R777, 2007.[Abstract/Free Full Text]
  18. Mehta PA, Cowie MR. Gender and heart failure: a population perspective. Heart 92, Suppl 3:iii14–iii18, 2006.[Free Full Text]
  19. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 47: 1019–1026, 2006.[Free Full Text]
  20. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC Jr, Sopko G, Taylor AL, Walsh BW, Wenger NK, and Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109: 672–693, 2004.
  21. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11: 319–329, 2000.[Abstract/Free Full Text]
  22. Ojeda NB, Grigore D, Yanes LL, Iliescu R, Robertson EB, Zhang H, Alexander BT. Testosterone contributes to marked elevations in mean arterial pressure in adult male intrauterine growth restricted offspring. Am J Physiol Regul Integr Comp Physiol 292: R758–R763, 2007.[Abstract/Free Full Text]
  23. Paul RJ, Bowman PS, Johnson J, Martin AF. Effects of gender and estrogen on myosin COOH-terminal isoforms and contractility in rat aorta. Am J Physiol Regul Integr Comp Physiol 292: R751–R757, 2007.[Abstract/Free Full Text]
  24. Perucca J, Bouby N, Valeix P, Bankir L. Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol 292: R700–R705, 2007.[Abstract/Free Full Text]
  25. Petre RE, Quaile MP, Rossman EJ, Ratcliffe SJ, Bailey BA, Houser SR, Margulies KB. Sex-based differences in myocardial contractile reserve. Am J Physiol Regul Integr Comp Physiol 292: R810–R818, 2007.[Abstract/Free Full Text]
  26. Rayner K, Chen Y-X, Hibbert B, White D, Miller H, Postel EH, O’Brien ER. NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis. Am J Physiol Regul Integr Comp Physiol 292: R743–R750, 2007.[Abstract/Free Full Text]
  27. Rogers JL, Mitchell AR, Maric C, Sandberg K, Myers A, Mulroney SE. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol 292: R794–R799, 2007.[Abstract/Free Full Text]
  28. Ryan MJ, McLemore GR Jr. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus. Am J Physiol Regul Integr Comp Physiol 292: R736–R742, 2007.[Abstract/Free Full Text]
  29. Sullivan JC, Sasser JM, Pollock JS. Sexual dimorphism in oxidant status in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 292: R764–R768, 2007.[Abstract/Free Full Text]
  30. Thawornkaiwong A, Pantharanontaga J, Wattanapermpool J. Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication. Am J Physiol Regul Integr Comp Physiol 292: R844–R851, 2007.[Abstract/Free Full Text]
  31. Vary TC, Kimball SR, Sumner A. Sex-dependent differences in the regulation of myocardial protein synthesis following long-term ethanol consumption. Am J Physiol Regul Integr Comp Physiol 292: R778–R787, 2007.[Abstract/Free Full Text]
  32. Yamaleyeva LM, Gallagher PE, Vinsant S, Chappell MC. Discoordinate regulation of renal nitric oxide synthase isoforms in ovariecotmized mRen2.Lewis rats. Am J Physiol Regul Integr Comp Physiol 292: R819–R826, 2007.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/R697    most recent
00766.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denton, K.
Right arrow Articles by Baylis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denton, K.
Right arrow Articles by Baylis, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.